Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Tyra Biosciences, Inc. (TYRA) had Weighted-Average Shares Outstanding (Diluted) of 57.22M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-86.48M |
|
-- |
|
-- |
|
$104.18M |
|
$-104.18M |
|
$17.70M |
|
$-86.48M |
|
$-86.48M |
|
$-86.48M |
|
$-86.48M |
|
$-86.48M |
|
$-86.48M |
|
$-104.18M |
|
$-103.66M |
|
57.22M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
57.22M |
$-1.51 |
|
$-1.51 |
|
| Balance Sheet Financials | |
$347.46M |
|
$1.65M |
|
$16.09M |
|
$363.56M |
|
$14.59M |
|
-- |
|
$5.81M |
|
$20.41M |
|
$343.15M |
|
$343.15M |
|
$343.15M |
|
50.75M |
|
| Cash Flow Statement Financials | |
$-69.77M |
|
$-98.40M |
|
$202.14M |
|
$59.01M |
|
$92.97M |
|
$33.96M |
|
$22.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
23.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-70.44M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-25.20% |
|
-25.20% |
|
-23.79% |
|
-25.20% |
|
$6.76 |
|
$-1.23 |
|
$-1.22 |
|